Introduction: The ARR Deception
AI startups are reporting record revenue figures, but a growing number of these numbers are built on sand. Scott Stevenson, CEO of legal AI startup Spellbook, recently exposed a 'huge scam': the inflation of Annual Recurring Revenue (ARR) by substituting contracted ARR (CARR) or annualized run-rate revenue. This practice is not new, but the AI hype cycle has amplified it. According to TechCrunch, sources confirm that fudged ARR is common, with some startups reporting CARR as ARR even when a significant portion of that revenue may never materialize. For executives and investors, this creates a dangerous information asymmetry: public metrics are unreliable, and the true health of AI startups is obscured.
The Mechanics of ARR Inflation
Contracted ARR (CARR) vs. Traditional ARR
ARR was designed to measure revenue from signed, multiyear contracts where the product is already deployed. CARR, however, includes contracts that are signed but not yet implemented. Bessemer Venture Partners notes that CARR should be adjusted for churn and downsell, but many startups skip this step. One VC told TechCrunch that CARR can be 70% higher than actual ARR. For example, a startup might count a three-year contract with heavy discounts in the first two years as full ARR, even if the customer is likely to churn before paying full price.
Annualized Run-Rate Revenue
Another tactic is using annualized run-rate revenue, extrapolating a single month or quarter's revenue over 12 months. For AI companies with usage-based pricing, this is highly misleading. A spike in usage from one large customer can create a false impression of sustainable growth.
Strategic Consequences
Winners and Losers
Winners: Early-stage VCs and founders benefit from inflated valuations, enabling them to raise larger rounds and attract talent. They can exit before the correction hits. Losers: Late-stage investors who overpay based on inflated metrics face write-downs. Honest startups that report accurate ARR are at a competitive disadvantage, struggling to attract attention and capital.
Market Impact
This behavior normalizes metric manipulation as a fundraising tactic. If left unchecked, it could lead to a market correction when public markets demand audited metrics. The AI sector risks a credibility crisis similar to the dot-com bust, where inflated revenue claims led to a collapse in trust.
Second-Order Effects
Regulatory scrutiny may increase. The SEC has previously penalized companies for misleading revenue metrics. If AI startups continue to inflate ARR, regulators could impose stricter reporting standards. Additionally, talent acquisition becomes distorted: top engineers and executives flock to startups with flashy revenue numbers, only to discover the real metrics are weaker. This misallocation of talent harms the entire ecosystem.
Executive Action
- Demand audited revenue metrics: When evaluating AI startups, require GAAP revenue or audited ARR. Do not rely on press releases or pitch decks.
- Cross-reference with customer concentration: High ARR from a few customers is a red flag. Ask for churn rates and implementation timelines.
- Monitor for CARR reporting: If a startup uses CARR, ask for the adjustment factors and historical realization rates.
Why This Matters
If you are investing in or partnering with AI startups, inflated ARR can lead to overpayment, poor due diligence, and eventual write-offs. The current environment rewards hype over substance, but the correction is inevitable. Acting now to verify metrics protects your capital and positions you ahead of the market.
Final Take
ARR inflation is a systemic risk in AI startup funding. While early-stage players benefit, the long-term damage to trust and market stability is severe. Executives must demand transparency and hold startups accountable. The AI gold rush is real, but the metrics are often fool's gold.
Rate the Intelligence Signal
Intelligence FAQ
Request audited financials, check for GAAP revenue, and ask for a breakdown of ARR into deployed vs. contracted. Look for high customer concentration and long implementation timelines.
If the startup has raised from institutional investors or plans an IPO, inflated ARR could lead to SEC investigations, shareholder lawsuits, and reputational damage. Misleading public statements violate securities laws.

